Protein Modification, Translational
"Protein Modification, Translational" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the enzymatically catalyzed modifications of the individual AMINO ACIDS of PROTEINS, and enzymatic cleavage or crosslinking of peptide chains that occur pre-translationally (on the amino acid component of AMINO ACYL TRNA), co-translationally (during the process of GENETIC TRANSLATION), or after translation is completed (POST-TRANSLATIONAL PROTEIN PROCESSING).
MeSH Number(s)
G02.111.087.675.871.790
G02.111.087.693
G02.149.115.675.871.790
G02.149.115.693
G03.495.770.871.790
G05.355.315.670
Concept/Terms
Protein Modification, Translational- Protein Modification, Translational
- Protein Modifications, Translational
- Translational Protein Modifications
- Protein Processing, Translational
- Translational Protein Modification
- Translational Protein Processing
Pre-Translational Amino Acid Modification- Pre-Translational Amino Acid Modification
- Pre Translational Amino Acid Modification
- Amino Acid Modification, Pre-Translational
- Amino Acid Modification, Pre Translational
- Pretranslational Amino Acid Modification
- Amino Acid Modification, Pretranslational
Co-Translational Protein Modification- Co-Translational Protein Modification
- Co-Translational Protein Modifications
- Modification, Co-Translational Protein
- Modifications, Co-Translational Protein
- Protein Modifications, Co-Translational
- Cotranslational Protein Modification
- Cotranslational Protein Modifications
- Protein Modification, Cotranslational
- Protein Modifications, Cotranslational
- Protein Modification, Co-Translational
- Protein Modification, Co Translational
- Co-Translational Protein Processing
- Co Translational Protein Processing
- Processing, Co-Translational Protein
- Protein Processing, Co-Translational
- Protein Processing, Co Translational
- Cotranslational Protein Processing
- Protein Processing, Cotranslational
Below are MeSH descriptors whose meaning is more general than "Protein Modification, Translational".
Below are MeSH descriptors whose meaning is more specific than "Protein Modification, Translational".
This graph shows the total number of publications written about "Protein Modification, Translational" by people in Harvard Catalyst Profiles by year, and whether "Protein Modification, Translational" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
Below are the most recent publications written about "Protein Modification, Translational" by people in Profiles.
-
Revealing nascent RNA processing dynamics with nano-COP. Nat Protoc. 2021 03; 16(3):1343-1375.
-
Testosterone supplementation upregulates androgen receptor expression and translational capacity during severe energy deficit. Am J Physiol Endocrinol Metab. 2020 10 01; 319(4):E678-E688.
-
ß-Methylamino-L-alanine substitution of serine in SOD1 suggests a direct role in ALS etiology. PLoS Comput Biol. 2019 07; 15(7):e1007225.
-
Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin. J Neurochem. 2018 12; 147(6):831-848.
-
Traffic-derived particulate matter exposure and histone H3 modification: A repeated measures study. Environ Res. 2017 Feb; 153:112-119.
-
The role of a conserved membrane proximal cysteine in altering aPS2CßPS integrin diffusion. Phys Biol. 2016 11 15; 13(6):066005.
-
Epigenetic Modifications of Histones in Periodontal Disease. J Dent Res. 2016 Feb; 95(2):215-22.
-
Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach. Mol Pharmacol. 2015 Feb; 87(2):286-95.
-
LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset. Am J Med Genet A. 2013 Jul; 161A(7):1599-611.
-
Overexpression of MyrAkt1 in endothelial cells leads to erythropoietin- and BMP4-independent splenic erythropoiesis in mice. PLoS One. 2013; 8(1):e55095.